Your browser doesn't support javascript.
Global Perspective on Telemedicine for Parkinson's Disease.
Shalash, Ali; Spindler, Meredith; Cubo, Esther.
  • Shalash A; Department of Neurology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
  • Spindler M; Department of Neurology, University of Pennsylvania, Philadelphia, PA, USA.
  • Cubo E; Neurology Department, Hospital University of Burgos, Burgos, Spain.
J Parkinsons Dis ; 11(s1): S11-S18, 2021.
Article in English | MEDLINE | ID: covidwho-1083887
Semantic information from SemMedBD (by NLM)
1. Telemedicine TREATS Parkinson Disease
Subject
Telemedicine
Predicate
TREATS
Object
Parkinson Disease
2. Movement Disorders PROCESS_OF Patients
Subject
Movement Disorders
Predicate
PROCESS_OF
Object
Patients
3. Parkinson Disease PROCESS_OF Patients
Subject
Parkinson Disease
Predicate
PROCESS_OF
Object
Patients
4. WASF1 gene|WASF1 AUGMENTS Experience
Subject
WASF1 gene|WASF1
Predicate
AUGMENTS
Object
Experience
5. Telemedicine TREATS Parkinson Disease
Subject
Telemedicine
Predicate
TREATS
Object
Parkinson Disease
6. Movement Disorders PROCESS_OF Patients
Subject
Movement Disorders
Predicate
PROCESS_OF
Object
Patients
7. Parkinson Disease PROCESS_OF Patients
Subject
Parkinson Disease
Predicate
PROCESS_OF
Object
Patients
8. WASF1 gene|WASF1 AUGMENTS Experience
Subject
WASF1 gene|WASF1
Predicate
AUGMENTS
Object
Experience
ABSTRACT
Telemedicine programs are particularly suited to evaluating patients with Parkinson's disease (PD) and other movement disorders, primarily because much of the physical exam findings are visual. Telemedicine uses information and communication technologies to overcome geographical barriers and increase access to healthcare service. It is particularly beneficial for rural and underserved communities, groups that traditionally suffer from lack of access to healthcare. There is a growing evidence of the feasibility of telemedicine, cost and time savings, patients' and physicians' satisfaction, and its outcome and impact on patients' morbidity and quality of life. In addition, given the unusual current situation with the COVID-19 pandemic, telemedicine has offered the opportunity to address the ongoing healthcare needs of patients with PD, to reduce in-person clinic visits, and human exposures (among healthcare workers and patients) to a range of infectious diseases including COVID-19. However, there are still several challenges to widespread implementation of telemedicine including the limited performance of parts of the neurological exam, limited technological savvy, fear of loss of a personal connection, or uneasiness about communicating sensitive information. On the other hand, while we are facing the new wave of COVID-19 pandemic, patients and clinicians are gaining increasing experience with telemedicine, facilitating equity of access to specialized multidisciplinary care for PD. This article summarizes and reviews the current state and future directions of telemedicine from a global perspective.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Parkinson Disease / Telemedicine Type of study: Randomized controlled trials Topics: Long Covid Limits: Humans Language: English Journal: J Parkinsons Dis Year: 2021 Document Type: Article Affiliation country: JPD-202411

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Parkinson Disease / Telemedicine Type of study: Randomized controlled trials Topics: Long Covid Limits: Humans Language: English Journal: J Parkinsons Dis Year: 2021 Document Type: Article Affiliation country: JPD-202411